Lipoproteins, LDL

"Lipoproteins, LDL" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues.

Descriptor ID	D008077
MeSH Number(s)	D10.532.515 D12.776.521.550
Concept/Terms	Lipoproteins, LDL Lipoproteins, LDL LDL Lipoproteins Low-Density Lipoproteins Lipoproteins, Low-Density Low Density Lipoproteins beta-Lipoproteins beta Lipoproteins LDL-1 LDL-1 LDL1 Low-Density Lipoprotein 1 Low Density Lipoprotein 1 LDL(1) LDL-2 LDL-2 LDL2 Low-Density Lipoprotein 2 Low Density Lipoprotein 2 LDL(2)

Below are MeSH descriptors whose meaning is more general than "Lipoproteins, LDL".

Chemicals and Drugs [D]
Lipids [D10]
Lipoproteins [D10.532]
Lipoproteins, LDL [D10.532.515]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Lipoproteins [D12.776.521]
Lipoproteins, LDL [D12.776.521.550]

Below are MeSH descriptors whose meaning is related to "Lipoproteins, LDL".

Below are MeSH descriptors whose meaning is more specific than "Lipoproteins, LDL".

Lipoproteins, LDL
Cholesterol, LDL

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lipoproteins, LDL" by people in this website by year, and whether "Lipoproteins, LDL" was a major or minor topic of these publications.

Bar chart showing 26 publications over 15 distinct years, with a maximum of 5 publications in 2004

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	1	1	2
2000	0	1	1
2002	0	1	1
2003	1	0	1
2004	4	1	5
2005	1	0	1
2006	1	0	1
2008	1	3	4
2009	0	1	1
2011	1	1	2
2012	1	0	1
2013	1	0	1
2014	1	1	2
2019	1	1	2
2020	0	1	1

Below are the most recent publications written about "Lipoproteins, LDL" by people in Profiles.

Mohammad Mirzaei N, Weintraub WS, Fok PW. An integrated approach to simulating the vulnerable atherosclerotic plaque. Am J Physiol Heart Circ Physiol. 2020 10 01; 319(4):H835-H846.

View in: PubMed
Madan N, Ghazi AR, Kong X, Chen ES, Shaw CA, Edelstein LC. Functionalization of CD36 cardiovascular disease and expression associated variants by interdisciplinary high throughput analysis. PLoS Genet. 2019 07; 15(7):e1008287.

View in: PubMed
Hou X, Summer R, Chen Z, Tian Y, Ma J, Cui J, Hao X, Guo L, Xu H, Wang H, Liu H. Lipid Uptake by Alveolar Macrophages Drives Fibrotic Responses to Silica Dust. Sci Rep. 2019 01 23; 9(1):399.

View in: PubMed
Zhang P, Policha A, Tulenko T, DiMuzio P. Autologous human plasma in stem cell culture and cryopreservation in the creation of a tissue-engineered vascular graft. J Vasc Surg. 2016 Mar; 63(3):805-14.

View in: PubMed
Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, Brown WV, Bruckert E, Defesche J, Lin KK, Livingston M, Mata P, Parhofer KG, Raal FJ, Santos RD, Sijbrands EJ, Simpson WG, Sullivan DR, Susekov AV, Tomlinson B, Wiegman A, Yamashita S, Kastelein JJ. Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation. J Clin Lipidol. 2014 Mar-Apr; 8(2):148-72.

View in: PubMed
Puri R, Nissen SE, Libby P, Shao M, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Raichlen JS, Uno K, Kataoka Y, Nicholls SJ. C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy. Circulation. 2013 Nov 26; 128(22):2395-403.

View in: PubMed
Benson M, Hossain J, Caulfield MP, Damaso L, Gidding S, Mauras N. Lipoprotein subfractions by ion mobility in lean and obese children. J Pediatr. 2012 Dec; 161(6):997-1003.

View in: PubMed
Mintzer S, Skidmore CT, Rankin SJ, Chervoneva I, Pequinot E, Capuzzi DM, Sperling MR. Conversion from enzyme-inducing antiepileptic drugs to topiramate: effects on lipids and C-reactive protein. Epilepsy Res. 2012 Jan; 98(1):88-93.

View in: PubMed
Thompson J, Wilson P, Brandewie K, Taneja D, Schaefer L, Mitchell B, Tannock LR. Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy. Am J Pathol. 2011 Sep; 179(3):1179-87.

View in: PubMed
Teo KK, Sedlis SP, Boden WE, O'Rourke RA, Maron DJ, Hartigan PM, Dada M, Gupta V, Spertus JA, Kostuk WJ, Berman DS, Shaw LJ, Chaitman BR, Mancini GB, Weintraub WS. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial. J Am Coll Cardiol. 2009 Sep 29; 54(14):1303-8.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement